FindTrial
Sign In

RT001

DRUG7 trials

Sponsors

Revance Therapeutics, Inc., Biojiva LLC

Conditions

Amyotrophic Lateral SclerosisCrow's FeetFacial WrinklesFriedreich's AtaxiaInfantile Neuroaxonal DystrophyLateral Canthal LinesProgressive Supranuclear Palsy

Phase 2

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
CompletedNCT00888914
Revance Therapeutics, Inc.Crow's Feet, Facial Wrinkles, Lateral Canthal Lines
Start: 2008-11-30End: 2009-02-28Updated: 2013-11-19
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
CompletedNCT00907387
Revance Therapeutics, Inc.Lateral Canthal Lines
Start: 2009-04-30End: 2009-10-31Updated: 2014-01-17
Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
CompletedNCT01124565
Revance Therapeutics, Inc.Crow's Feet, Facial Wrinkles, Lateral Canthal Lines
Start: 2010-05-31End: 2010-07-31Updated: 2014-01-17
A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy
Active, not recruitingNCT03570931
Biojiva LLCInfantile Neuroaxonal Dystrophy
Start: 2018-11-05End: 2022-06-30Updated: 2021-10-14
RT001 in Amyotrophic Lateral Sclerosis
CompletedNCT04762589
Biojiva LLCAmyotrophic Lateral Sclerosis
Start: 2021-03-10End: 2022-06-28Updated: 2025-07-01
RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY
NCT04937530
Biojiva LLCProgressive Supranuclear Palsy
Start: 2021-06-23End: 2022-08-30Target: 40Updated: 2021-06-25

Phase 3

A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia
CompletedNCT04102501
Biojiva LLCFriedreich's Ataxia
Start: 2019-10-30End: 2021-08-23Updated: 2022-05-27